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After many hours spent exploring Web sites of clinics and 
discussing with other patients across the globe, a Swed-
ish couple decides the only way to treat their child’s dis-
ease is to venture to China to gain access to new stem cell 
therapies not available in their home country. At the same 
time a Swedish researcher, who is increasingly concerned 
by the flourishing of promissory and yet unproven stem 
cell therapies around the globe, joins forces with British re-
searchers to draw on stem cell lines derived from an in vitro 
fertilization (IVF) embryo to explore the mechanisms of this 
very disease. Yet another group of British researchers tin-
kers with transgenic mice to achieve a similar aim (research 
that is co-sponsored by a US-American patient organiza-
tion, but that a trans-national group of animal rights ac-
tivists finds deeply worrisome). Roughly a thousand miles 
toward the South, an Italian woman in her early 40s makes 
arrangements with a fertility center to be able to draw on 
egg cells that had been donated by another woman, an 
arrangement that she makes over phone and in English 
with a Ukrainian fertility center as egg donation is not le-
gally available in her home country and offered at prices 
that she cannot afford in countries closer to her home. De-
tached from these locations and spaces and yet somehow 
connected, policy-makers in Brussels ponder over how to 
integrate these various promissory objects and concerned 
subjects into European innovation policies, to make sure 
that Europe does not miss the opportunity that stem cells 
offer toward a knowledge-based future.
These instances take place in different spaces and they in-
volve very different subjects and objects, as well as a range 
of novel biological forms that cannot be easily classified 
along  conventional  categories.  Yet,  what  might  we 
learn if we cease to treat them as different phenom-
ena? What might we learn from bringing these different 
objects together and explore their similarities and differ-
ences? And how might the knowledge generated through 
such a convergence enhance both our understanding of 
how we know and make sense of our world as well as how 
we approach and choose to live in it? Most importantly, 
they deal with the issue of “life” and raise questions about 
how life enters into the picture. Doctors confront such an 
issue routinely through their engagement with reproduc-
tive medicine and its converse, dealing with the end of life 
itself when managing death. But our story above suggests 
that “life” is entering the picture in new ways and crossing 
boundaries – between human and human, human and 
animal, the natural and unnatural, and between the very 
meaning of life and death.
Questions of such kinds inform the recently established 
international  research  network,  “Bio-objects  and  their 
Boundaries: Governing Matters at the Intersection of So-
ciety, Science and Politics,” launched in December 2010. 
This “Action”, funded by the European Cooperation in Sci-
ence and Technology (COST) framework, comprises a very 
heterogeneous group of young and more experienced re-
searchers from a variety of disciplines and fields of inquiry, 
ranging from science studies, philosophy, through to the 
life sciences, a network under the formal oversight of the 
co-authors (Box 1) (1).
All members engage with bio-medical and bio-techno-
logical innovation processes in their daily lives as research-
ers in our home institutions. For instance, some of us work 
with human embryonic stem cell (hESC) lines on benches 
in laboratories, others venture into cross-country compari-
sons of the regulatory settlements of hESC research, while 
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Box 1. European Cooperation in Science and Technology 
(CoST) Action IS1001: “Bio-objects and their Boundaries: 
Governing Matters at the Intersection of Society, Politics, 
and Science”
•  This Action, a research network, is funded by COST.
•  It was launched in December 2010 and is scheduled to run 
until December 2014.
•  Web site: http://www.bioobjects.eu.
still others follow hESCs and hESC scientists in their daily 
work on benches and desk tops to get a better sense of 
what is going on. In this Action, all of us bring our indi-
vidual experiences, insights and findings, as well as ques-
tions and puzzles, in order to share them, exchange them, 
and to learn from this synergy. Indeed, a central tenet of 
this collaborative endeavor is the understanding that while 
discrete  bio-medical  and  bio-technological  innovation 
processes and their products have different effects and im-
plications in different spaces and domains, much can be 
learnt if we overcome disciplinary boundaries, and try to 
assemble these different objects – as well as the research-
ers  that  conduct  research  on  them  or  that  help  make 
them in the first place. We venture into such an endeavor 
through the concept of “bio-objects.”
BIo-oBjECTS And BIo-oBjECTIfICATIon ProCESSES
From a descriptive perspective, bio-objects are meant to 
refer to, first, creatures that have been made at the work 
benches of the life sciences, such as genetically-modified 
organisms or transpecies animals, as well as, second, enti-
ties that we are, by now, much more familiar with but that 
have been brought into new spaces, such as stem cells 
that are removed from the cord blood after deliveries and 
stored in cord blood banks, IVF embryos that dwell in Petri 
dishes in laboratories, or human tissue samples that have 
been cut from a patient’s body, frozen for storage and kept 
in a tissue repository, together with her clinical records and 
life-style information. For sure, all these instances of bio-
objects are distinct in biological terms, and they come with 
their own histories and challenges, and yet they nonethe-
less share a number of similarities.
First, they are the products of various efforts to know and 
enhance (human) life – that is bio(s)–, through intervening 
in and objectifying it, that is through creating often very 
tangible objects that can be leveraged and stored, as well 
as circulated and exchanged. Such objects might be the 
product of efforts to redirect living processes in laborato-
ries; yet, they might also take a less “wet” shape – such as in 
aggregation of numbers of patients and research subjects 
in clinical studies. Second, they tend to be characterized by 
ever-greater fluidity and mobility across different domains. 
This means that a bio-object associated with biomedical 
research may find its way into the food system or the en-
vironment or become part of a repository (as in biobanks). 
Third, they tend to disrupt the conventional boundaries 
and identities of biological forms and categories, such as 
the boundaries between human and animals or between 
the natural and artificial, sitting ambiguously in between 
those entities that we tend to conceptualize as human 
subjects and as non-human objects instead, sometimes 
troubling or even unsettling this very distinction. Last but 
not least, they tend to trigger very different and some-
times contrasting demands. They are often imbued with 
hopes, promising to enhance our knowledge on health 
and disease, to regenerate body parts or, sometimes, ail-
ing economies, rendering our collective life safer, healthier, 
and more productive (2,3). They are closely tied to ways 
in which European identity is imagined at the beginning 
of the 21st century. Yet, bio-objects also trigger a range of 
concerns. Such concerns range from citizens who are up-
set by the “objectification” of IVF embryos or concerned by 
the trading of egg cells, to policy makers who might not 
be concerned by the proliferation and circulation of these 
objects but by their uneven paths of development and by 
the difficulties and uncertainties in which some of these 
ambiguous objects are entangled in when they are moved 
to clinics or the markets. This was evident, for example, 
during the recent debate in Europe over how to classify 
tissue-engineered products or therapies that involve the 
manipulation and reconfiguring of cells – was the result 
to be a device, a drug, a medicine? At one point, the Eu-
ropean Medicines Agency had over 25 competing defini-
tions, a situation only resolved by the creation of the term 
“Advanced Therapy Medicinal Products,” a concept found 
nowhere else in the regulatory world.
These features imply that it is not very instructive to con-
ceptualize bio-objects as stable entities. Rather, we should 
see them as “boundary crawlers” (4) that move and are 
moved  across  different  domains,  engendering  different 
and sometimes conflicting demands, and as always only 
the preliminary product of ongoing processes to tame life 
and to render it more productive. This is why we do not 
take them as in some way “given,” a pre-defined class of 
entities; instead, we find it more useful to explore them 
as a result of “bio-objectification” processes, that is those 
technological interventions and labors through which 
we seek to tame or control life but typically in do-BIO-OBJECTS 650 Croat Med J. 2011; 52: 648-50
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ing so render it more open to contestation, located in new 
spaces of significance. How this works out in practice in dif-
ferent spaces, is the major question that we seek to tackle 
in our collaborative research effort.
BoUndArIES, GoVErnAnCE, And GEnErATIVE
rELATIonS
In our Action, we explore bio-objects and bio-objectifica-
tion processes along three axes – each of which is orga-
nized into a “working group” that draws on members’ cur-
rent research and disciplinary expertise to explore a range 
of substantive issues within a specific domain. Working 
group 1 explores boundary changes between human and 
non-human and living and non-living. Working group 2 
compares the modes in which bio-objects are governed 
at different levels, ranging from efforts at a global scale 
down to nation states and their institutions as more tradi-
tional sites of governance to practices of self-governance 
of individuals such as patients. Working Group 3 seeks to 
explore what we conceptualize as “generative relations,” 
that is those economic, political, or social contexts that fa-
cilitate bio-objectification processes, and which – in turn – 
are themselves shaped or reified through such processes 
(Box 2).
The objectives of our collaborative effort are, first, to devel-
op a conceptual repertoire that helps us grasp these pro-
cesses and that is also helpful for life scientists and biomed-
ical researchers as well as informative for policy makers. A 
second objective of this Action relates to network building 
(Box 3). Indeed, a consistent part of our network consists 
of scholars who have participated in a Marie Curie Training 
Programme at the Science and Technology Studies Unit at 
the Department of York. In the meantime, the launch of 
this Action has helped us enrich this network with other 
young scholars, as well as more experienced ones, and 
new participants are welcome to attend one of our public 
events, or to join one of our working groups. In the mean-
time, readers will have the opportunity to learn more on 
this Action in the forthcoming issues of this journal.
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Box 2. Working Groups
•  Working group 1: Boundary changes betwe  en human/non-
human and living/non-living.
Work  ing group 1 examines the changing boundaries of the hu-
man, nonhuman, and society with the emergence of new and 
changing bio-objects.
•  Working group 2: The governance of bio-objects
The second Working Group examines the governance of new 
bio-objects, and the socio-cultural and political regulations in-
volved in the boundary shifts that they bring about.
•  Working Group 3: Bio-objects and their “generative relations”
The third working group explores the emergence of new kinds 
of social and economic relations prompted by processes of 
“bio-objectification.” 
Box 3. objectives
•  The first objective of this Action is to improve our understand-
ing of processes of new scientific and technological develop-
ment, in particular the making, trading, and socio-cultural use 
of new bio-objects emerging at present in Europe, in order to 
strengthen Europe’s capacity to both exploit and manage the 
intended and unintended effects of these processes.
•  A second objective relates to capacity building, aiming at the 
building of a strong network that unites young researchers and 
more experienced ones with different disciplinary backgrounds 
from different European countries.